Adial Pharmaceuticals Ownership 2024 | Who Owns Adial Pharmaceuticals Now?
Institutional Ownership
8.52%
Insider Ownership
1.76%
Retail Ownership
89.72%
Institutional Holders
17.00
Adial Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -187 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -29,705 | -100.00% | - | Sep 30, 2023 |
TRUIST FINANCIAL CORP | - | - | - | -33,862 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -535 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -17,623 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -137,464 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -194,364 | -100.00% | - | Sep 30, 2023 |
MANCHESTER CAPITAL MANAGEMENT LLC | - | - | - | -1,202,452 | -100.00% | - | Sep 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -13,088 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -20,691 | -100.00% | - | Sep 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -26,473 | -100.00% | - | Sep 30, 2023 |
CREATIVE PLANNING | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -24,046 | -100.00% | - | Sep 30, 2023 |
Adial Pharmaceuticals's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -187 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -29,705 | -100.00% | - | Sep 30, 2023 |
TRUIST FINANCIAL CORP | - | - | - | -33,862 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -535 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -17,623 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -137,464 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -194,364 | -100.00% | - | Sep 30, 2023 |
MANCHESTER CAPITAL MANAGEMENT LLC | - | - | - | -1,202,452 | -100.00% | - | Sep 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -13,088 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -20,691 | -100.00% | - | Sep 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -26,473 | -100.00% | - | Sep 30, 2023 |
CREATIVE PLANNING | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -24,046 | -100.00% | - | Sep 30, 2023 |
The largest Adial Pharmaceuticals shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Adial Pharmaceuticals (ADIL), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -187 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -535 | -100.00% | - | Sep 30, 2023 |
CREATIVE PLANNING | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -13,088 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -17,623 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -20,691 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -24,046 | -100.00% | - | Sep 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -26,473 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -29,705 | -100.00% | - | Sep 30, 2023 |
TRUIST FINANCIAL CORP | - | - | - | -33,862 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -137,464 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -194,364 | -100.00% | - | Sep 30, 2023 |
MANCHESTER CAPITAL MANAGEMENT LLC | - | - | - | -1,202,452 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Adial Pharmaceuticals's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.19K stocks of ADIL, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MANCHESTER CAPITAL MANAGEMENT LLC | - | - | - | -1,202,452 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -194,364 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -137,464 | -100.00% | - | Sep 30, 2023 |
TRUIST FINANCIAL CORP | - | - | - | -33,862 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -29,705 | -100.00% | - | Sep 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -26,473 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -24,046 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -20,691 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -17,623 | -100.00% | - | Sep 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -13,088 | -100.00% | - | Sep 30, 2023 |
CREATIVE PLANNING | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -535 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -187 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Adial Pharmaceuticals's biggest institutional seller is MANCHESTER CAPITAL MANAGEMENT LLC. The company sold -1.20M shares of ADIL, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MANCHESTER CAPITAL MANAGEMENT LLC | - | - | - | -1,202,452 | -100.00% | - | Sep 30, 2023 |
BLACKROCK INC. | - | - | - | -194,364 | -100.00% | - | Sep 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -137,464 | -100.00% | - | Sep 30, 2023 |
TRUIST FINANCIAL CORP | - | - | - | -33,862 | -100.00% | - | Sep 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -29,705 | -100.00% | - | Sep 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -26,473 | -100.00% | - | Sep 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -24,046 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA SECURITIES, LLC | - | - | - | -20,691 | -100.00% | - | Sep 30, 2023 |
TWO SIGMA INVESTMENTS, LP | - | - | - | -17,623 | -100.00% | - | Sep 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -13,088 | -100.00% | - | Sep 30, 2023 |
CREATIVE PLANNING | - | - | - | -10,000 | -100.00% | - | Sep 30, 2023 |
MORGAN STANLEY | - | - | - | -535 | -100.00% | - | Sep 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -187 | -100.00% | - | Sep 30, 2023 |
Adial Pharmaceuticals's largest sold out institutional shareholder by shares sold is MANCHESTER CAPITAL MANAGEMENT LLC, sold -1.20M shares, valued at -, as of undefined.
Adial Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
FIDELITY CONCORD STREET TRUST | 0.00% | 126,140 | - | - | Feb 29, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 21,443 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 203,358 | - | - | Mar 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 30,310 | - | - | Jan 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 5,407 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 9,359 | -9,359 | -50.00% | Mar 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 3,176 | - | - | Jan 31, 2024 |
Dimensional ETF Trust | 0.00% | 1,100 | - | - | Jan 31, 2024 |
EQ ADVISORS TRUST | 0.00% | 2,336 | - | - | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 930 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 6,767 | - | - | Mar 31, 2024 |
Adial Pharmaceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 126.14K shares, compromising 0.00% of its total assets.
Adial Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 23 | 17 | -10.53% |
31 Mar, 23 | 19 | - |
31 Dec, 22 | 19 | -5.00% |
30 Sep, 22 | 20 | -23.08% |
30 Jun, 22 | 26 | 13.04% |
31 Mar, 22 | 23 | - |
31 Dec, 21 | 23 | 21.05% |
30 Sep, 21 | 19 | 11.76% |
30 Jun, 21 | 17 | - |
31 Mar, 21 | 17 | 41.67% |
31 Dec, 20 | 12 | -7.69% |
30 Sep, 20 | 13 | 44.44% |
30 Jun, 20 | 9 | - |
31 Mar, 20 | 9 | 12.50% |
31 Dec, 19 | 8 | -11.11% |
30 Sep, 19 | 9 | - |
30 Jun, 19 | 9 | -25.00% |
31 Mar, 19 | 12 | 50.00% |
31 Dec, 18 | 8 | 60.00% |
30 Sep, 18 | 5 | - |
As of 30 Jun 23, 17 institutions are holding Adial Pharmaceuticals's shares, representing a decrease of -10.53% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 23 | 2,253,587 | -6.89% |
31 Mar, 23 | 2,420,240 | 52.08% |
31 Dec, 22 | 1,591,440 | -15.48% |
30 Sep, 22 | 1,882,923 | 16.72% |
30 Jun, 22 | 1,613,169 | -47.81% |
31 Mar, 22 | 3,090,855 | 145.75% |
31 Dec, 21 | 1,257,731 | 4.36% |
30 Sep, 21 | 1,205,240 | 3.60% |
30 Jun, 21 | 1,163,398 | 56.64% |
31 Mar, 21 | 742,723 | 3.05% |
31 Dec, 20 | 720,742 | 6.09% |
30 Sep, 20 | 679,394 | -14.24% |
30 Jun, 20 | 792,225 | 28.38% |
31 Mar, 20 | 617,082 | 1.85% |
31 Dec, 19 | 605,869 | 0.96% |
30 Sep, 19 | 600,122 | -1.41% |
30 Jun, 19 | 608,709 | -19.99% |
31 Mar, 19 | 760,802 | 177.32% |
31 Dec, 18 | 274,342 | 1337.32% |
30 Sep, 18 | 19,087 | - |
Adial Pharmaceuticals (ADIL) has 2.25M shares outstanding as of 30 Jun 23, down -6.89% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 23 | 8.52% | 10.18% |
31 Mar, 23 | 9.15% | 22.64% |
31 Dec, 22 | 6.36% | 11.86% |
30 Sep, 22 | 7.32% | 16.63% |
30 Jun, 22 | 6.63% | 3.72% |
31 Mar, 22 | 13.35% | 33.25% |
31 Dec, 21 | 6.34% | 17.19% |
30 Sep, 21 | 6.07% | 13.88% |
30 Jun, 21 | 6.61% | 30.36% |
31 Mar, 21 | 4.67% | 13.96% |
31 Dec, 20 | 5.78% | 23.33% |
30 Sep, 20 | 4.98% | 10.11% |
30 Jun, 20 | 7.02% | 20.30% |
31 Mar, 20 | 5.88% | 17.65% |
31 Dec, 19 | 5.77% | 16.84% |
30 Sep, 19 | 5.85% | 16.51% |
30 Jun, 19 | 5.95% | 7.00% |
31 Mar, 19 | 9.22% | 83.40% |
31 Dec, 18 | 3.33% | 2808.14% |
30 Sep, 18 | 0.34% | - |
As of 30 Jun 23, Adial Pharmaceuticals is held by 8.52% institutional shareholders, representing a 10.18% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 23 | 3 | -57.14% |
31 Mar, 23 | 7 | -12.50% |
31 Dec, 22 | 8 | -20.00% |
30 Sep, 22 | 10 | -33.33% |
30 Jun, 22 | 15 | 50.00% |
31 Mar, 22 | 10 | 42.86% |
31 Dec, 21 | 7 | -46.15% |
30 Sep, 21 | 13 | 44.44% |
30 Jun, 21 | 9 | -18.18% |
31 Mar, 21 | 11 | 120.00% |
31 Dec, 20 | 5 | -28.57% |
30 Sep, 20 | 7 | 250.00% |
30 Jun, 20 | 2 | -33.33% |
31 Mar, 20 | 3 | 50.00% |
31 Dec, 19 | 2 | -50.00% |
30 Sep, 19 | 4 | 300.00% |
30 Jun, 19 | 1 | -90.00% |
31 Mar, 19 | 10 | 25.00% |
31 Dec, 18 | 8 | 60.00% |
30 Sep, 18 | 5 | - |
3 institutional shareholders have increased their position in ADIL stock as of 30 Jun 23 compared to 7 in the previous quarter (a -57.14% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 23 | 6 | - |
31 Mar, 23 | 6 | 100.00% |
31 Dec, 22 | 3 | 50.00% |
30 Sep, 22 | 2 | -33.33% |
30 Jun, 22 | 3 | - |
31 Mar, 22 | 3 | -40.00% |
31 Dec, 21 | 5 | 150.00% |
30 Sep, 21 | 2 | -50.00% |
30 Jun, 21 | 4 | 33.33% |
31 Mar, 21 | 3 | 50.00% |
31 Dec, 20 | 2 | 100.00% |
30 Sep, 20 | 1 | - |
30 Jun, 20 | 1 | - |
31 Mar, 20 | 1 | - |
31 Dec, 19 | - | -100.00% |
30 Sep, 19 | 1 | -66.67% |
30 Jun, 19 | 3 | 200.00% |
31 Mar, 19 | 1 | - |
31 Dec, 18 | - | - |
30 Sep, 18 | - | - |
6 institutional shareholders have reduced their position in ADIL stock as of 30 Jun 23 compared to 6 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 23 | 17 | -10.53% | 2,253,587 | -6.89% | 8.52% | 10.18% | 3 | -57.14% | 6 | - |
31 Mar, 23 | 19 | - | 2,420,240 | 52.08% | 9.15% | 22.64% | 7 | -12.50% | 6 | 100.00% |
31 Dec, 22 | 19 | -5.00% | 1,591,440 | -15.48% | 6.36% | 11.86% | 8 | -20.00% | 3 | 50.00% |
30 Sep, 22 | 20 | -23.08% | 1,882,923 | 16.72% | 7.32% | 16.63% | 10 | -33.33% | 2 | -33.33% |
30 Jun, 22 | 26 | 13.04% | 1,613,169 | -47.81% | 6.63% | 3.72% | 15 | 50.00% | 3 | - |
31 Mar, 22 | 23 | - | 3,090,855 | 145.75% | 13.35% | 33.25% | 10 | 42.86% | 3 | -40.00% |
31 Dec, 21 | 23 | 21.05% | 1,257,731 | 4.36% | 6.34% | 17.19% | 7 | -46.15% | 5 | 150.00% |
30 Sep, 21 | 19 | 11.76% | 1,205,240 | 3.60% | 6.07% | 13.88% | 13 | 44.44% | 2 | -50.00% |
30 Jun, 21 | 17 | - | 1,163,398 | 56.64% | 6.61% | 30.36% | 9 | -18.18% | 4 | 33.33% |
31 Mar, 21 | 17 | 41.67% | 742,723 | 3.05% | 4.67% | 13.96% | 11 | 120.00% | 3 | 50.00% |
31 Dec, 20 | 12 | -7.69% | 720,742 | 6.09% | 5.78% | 23.33% | 5 | -28.57% | 2 | 100.00% |
30 Sep, 20 | 13 | 44.44% | 679,394 | -14.24% | 4.98% | 10.11% | 7 | 250.00% | 1 | - |
30 Jun, 20 | 9 | - | 792,225 | 28.38% | 7.02% | 20.30% | 2 | -33.33% | 1 | - |
31 Mar, 20 | 9 | 12.50% | 617,082 | 1.85% | 5.88% | 17.65% | 3 | 50.00% | 1 | - |
31 Dec, 19 | 8 | -11.11% | 605,869 | 0.96% | 5.77% | 16.84% | 2 | -50.00% | - | -100.00% |
30 Sep, 19 | 9 | - | 600,122 | -1.41% | 5.85% | 16.51% | 4 | 300.00% | 1 | -66.67% |
30 Jun, 19 | 9 | -25.00% | 608,709 | -19.99% | 5.95% | 7.00% | 1 | -90.00% | 3 | 200.00% |
31 Mar, 19 | 12 | 50.00% | 760,802 | 177.32% | 9.22% | 83.40% | 10 | 25.00% | 1 | - |
31 Dec, 18 | 8 | 60.00% | 274,342 | 1337.32% | 3.33% | 2808.14% | 8 | 60.00% | - | - |
30 Sep, 18 | 5 | - | 19,087 | - | 0.34% | - | 5 | - | - | - |
Adial Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
The last insider buy of ADIL was made by Schuyler Kevin on Oct 03 2023, buying 700 shares at $2.74 per share (worth $1.92K).
Adial Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 7 | - | - |
Q3 2023 | 1 | - | - |
Q2 2023 | 12 | - | - |
Q4 2022 | - | 1 | - |
Q3 2022 | 5 | - | - |
Q2 2022 | 1 | - | - |
Q1 2022 | 9 | - | - |
Q4 2021 | 8 | 4 | 200.00% |
Q2 2021 | - | 1 | - |
Q1 2021 | 10 | - | - |
Q4 2020 | 5 | 4 | 125.00% |
Q3 2020 | - | 1 | - |
Q2 2020 | 1 | - | - |
Q1 2020 | 14 | - | - |
Q4 2019 | 1 | 1 | 100.00% |
Q1 2019 | 7 | - | - |
Q4 2018 | 16 | 5 | 320.00% |
Q3 2018 | 57 | 15 | 380.00% |
Q1 2018 | - | 8 | - |
Q4 2017 | - | 5 | - |
7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Adial Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q3 2023 | 1 | - | - |
Q2 2023 | - | - | - |
Q4 2022 | - | - | - |
Q3 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q4 2021 | 6 | 1 | 600.00% |
Q2 2021 | - | 1 | - |
Q1 2021 | - | - | - |
Q4 2020 | - | - | - |
Q3 2020 | - | 1 | - |
Q2 2020 | - | - | - |
Q1 2020 | 5 | - | - |
Q4 2019 | - | 1 | - |
Q1 2019 | 4 | - | - |
Q4 2018 | - | - | - |
Q3 2018 | 16 | - | - |
Q1 2018 | - | - | - |
Q4 2017 | - | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Adial Pharmaceuticals's stocks.
Adial Pharmaceuticals Peer Ownership
Ticker | Company |
---|---|
HOTH | Hoth Therapeutics, Inc. |
AXLA | Axcella Health Inc. |
RVPH | Reviva Pharmaceuticals Holdings, Inc. |
BPTH | Bio-Path Holdings, Inc. |
KTTA | Pasithea Therapeutics Corp. |
AEZS | Aeterna Zentaris Inc. |
ADTX | Aditxt, Inc. |
REVB | Revelation Biosciences, Inc. |
RNAZ | TransCode Therapeutics, Inc. |
TNXP | Tonix Pharmaceuticals Holding Corp. |
DFFN | CervoMed Inc. |
VRAX | Virax Biolabs Group Limited |
RNXT | RenovoRx, Inc. |
NRBO | NeuroBo Pharmaceuticals, Inc. |
ONTX | Traws Pharma, Inc. |
ATXI | Avenue Therapeutics, Inc. |
CBIO | Gyre Therapeutics, Inc. |
BNTC | Benitec Biopharma Inc. |
ALRN | Aileron Therapeutics, Inc. |
ADIL Ownership FAQ
Who Owns Adial Pharmaceuticals?
Adial Pharmaceuticals is owned by institutional shareholders (8.52%), insiders (1.76%), and public (89.72%). The largest institutional shareholder of Adial Pharmaceuticals is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Adial Pharmaceuticals?
Adial Pharmaceuticals's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, TRUIST FINANCIAL CORP, MORGAN STANLEY, and TWO SIGMA INVESTMENTS, LP. The top five shareholders own together 0% of the company's share outstanding.
How many Adial Pharmaceuticals shareholders are there?
As of Jun 2023, there are 17 institutional shareholders of Adial Pharmaceuticals.
What percentage of Adial Pharmaceuticals is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 0 shares of Adial Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).
What percentage of Adial Pharmaceuticals is owned by NORTHERN TRUST CORP?
As of Sep 2023, NORTHERN TRUST CORP holds 0 shares of Adial Pharmaceuticals (ADIL), compromising 0% of the company, valued at $0.
What percentage of Adial Pharmaceuticals is owned by TRUIST FINANCIAL CORP?
TRUIST FINANCIAL CORP is the third largest holder of Adial Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).